Clinical Research Fellow

We seek an ambitious, innovative individual with a specific interest in early phase clinical trials to act as sub-investigator for a growing portfolio of complex clinical trials.

The role offers an exciting opportunity to work with a highly motivated & empowered team to deliver innovative research. With Consultant oversight, you will be responsible for seeing new referrals, follow-ups & managing the patient throughout all aspects of their trial experience. Within ECMT there is a regular molecular tumour board meeting supporting both local & national studies. You will take an active role in these meetings gaining valuable experience in using the data to identify and define suitable trial options for patients.

This is a 10 session non-training post. The position is suitable for individuals post-FY2 through to those having completed their specialist training in Oncology, & who wish to gain further experience in experimental medicine & Phase I trials, including first-in-human trials, clinical pharmacology trials and translational research. You will work with a team of consultants, research nurses, clinical trials coordinators, translational research facilitators, secretarial support, rotating clinical fellows and specialty trainees. The ECM team delivers trials in all major solid tumour types.

Interviews are expected w/c 15 December 2025 (TBC).

Start date: Summer 2026

The portfolio includes a diverse range of clinical research trials. Following training, you will be expected to participate in these studies as a sub-investigator. These include phase I trials of small molecule inhibitors, next-generation chemotherapy trials, combination / multi-modality phase I trials, molecular characterisation / translational studies, radiotherapy trials.

You will be involved in managing all aspects of trial patients (both in outpatient & in-patients setting), across a diverse range of solid tumours, through new patient consultation, consent & screening patients & reviewing patients at follow-up appointments.

You will be expected to attend safety review committee meetings to discuss trial patients. This will involve close liaison with the Principal Investigators. In addition, you will interface with external stakeholders such as CROs & pharmaceutical sponsors.

You will be expected to attend monthly molecular tumour board meetings to discuss trial patients and to agree opportunities for patients to enrol in early phase trials.

You will be expected to undertake the administrative duties associated with the care of our patients. You will be given opportunities and will be encouraged to be involved in the development & planning of new studies.

There is potential to present your research work & you will be expected to be involved in writing papers & reviews. You will also be required to undergo an annual appraisal.

The Christie is one of Europe's leading cancer centres, treating over 60,000 patients a year. We are based in Manchester and serve a population of 3.2 million across Greater Manchester & Cheshire, but as a national specialist around 15% patients are referred to us from other parts of the country.

We provide radiotherapy through one of the largest radiotherapy departments in the world; chemotherapy on site and through 14 other hospitals; highly specialist surgery for complex and rare cancer; and a wide range of support and diagnostic services. We are also an international leader in research, with world first breakthroughs for over 100 years.

We run one of the largest early clinical trial units in Europe with over 300 trials every year. Cancer research in Manchester, most of which is undertaken on the Christie site, has been officially ranked the best in the UK.

The remit of the Experimental Cancer Medicine Team is to undertake cutting edge research in developing new therapeutics and conducting translational research in cancer patients. Phase I trials are an important first step in the drug development process and are not only designed to test the safety & tolerability of novel agents but interrogate new drug formulations, combinations, pharmacokinetics and pharmacodynamics.

The post holder will work as part of the Experimental Cancer Medicine Team, providing medical support to the consultants by primarily acting as sub-investigator on a large portfolio of clinical trials. The post holder, with consultant oversight, will be responsible for seeing new referrals, follow-ups and for managing the patient throughout all aspects of their trial experience. ECMT has a well-established and regular molecular tumour board meeting supporting both local and national studies. The post holder will take an active in these meetings gaining valuable experience in using these data to identify and define suitable trial options for patients. The post holder will have the opportunity to be involved in audit, writing papers and reviews and there is the potential to present research work at local, national, or international meetings. The post holder will join a highly motivated and empowered workforce to increase research capacity and deliver innovative early phase research in compliance with Good Clinical Practice (ICH-GCP) and Trust policy.